KILITCH

Kilitch Drugs(I) Share PriceKilitch Drugs(I)

₹349.65
-7.1 (-1.99%)
As on 10 December, 2023 | 22:35 BSE: 524500 NSE: KILITCHISIN: INE729D01010

Kilitch Drugs(I) Performance

Day Range

  • Low 349.65
  • High 349.65
₹ 349.65

52 Week Range

  • Low 125.00
  • High 364.25
₹ 349.65
  • Open Price0.00
  • Previous Close356.75
  • Volume2407

Start SIP in Kilitch Drugs(I)

Start SIP

Kilitch Drugs(I) Share Price

  • Over 1 Month 12.32%
  • Over 3 Month 69.73%
  • Over 6 Month 69.24%
  • Over 1 Year 116.7%

Kilitch Drugs(I) Key Statistics

P/E Ratio 40.1
PEG Ratio 0.6
Market Cap Cr 562
Price to Book Ratio 3.7
EPS 9.3
Dividend 0
Relative Strength Index 74.23
Money Flow Index 86.41
MACD Signal 15.82
Average True Range 6.75

Kilitch Drugs(I) Investment Rating

  • Master Rating:
  • Kilitch Drugs India has an operating revenue of Rs. 153.21 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 9% is okay, ROE of 6% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 18% and 64% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 97 which is a GREAT score indicating consistency in earnings, a RS Rating of 92 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock has great fundamentals and technical strength to stay in momentum.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Kilitch Drugs(I) Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 32314329222432
Operating Expenses Qtr Cr 26263724192028
Operating Profit Qtr Cr 6574334
Depreciation Qtr Cr 0000000
Interest Qtr Cr 0000000
Tax Qtr Cr 2121011
Net Profit Qtr Cr 4454433
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 122110
Operating Expenses Annual Cr 10194
Operating Profit Annual in Cr 1711
Depreciation Cr 11
Interest Annual Cr 11
Tax Annual Cr 43
Net Profit Annual Cr 1611
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 65
Cash from Investing Activity Annual Cr 6-16
Cash from Financing Annual Activity Cr 38
Net Cash Flow Annual Cr 15-3
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 196178
Fixed Assets Annual Cr 1614
Total Non Current Assets Annual Cr 138135
Total Current Assets Annual Cr 11598
Total Assets Annual Cr 252232
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 126114
ROE Annual % 86
ROCE Annual % 108
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1815
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 41374530313337
Operating Expenses Qtr Cr 33303926273032
Operating Profit Qtr Cr 9664435
Depreciation Qtr Cr 1111111
Interest Qtr Cr 2111211
Tax Qtr Cr 2121011
Net Profit Qtr Cr 5342223
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 143117
Operating Expenses Annual Cr 122104
Operating Profit Annual in Cr 1810
Depreciation Cr 42
Interest Annual Cr 51
Tax Annual Cr 43
Net Profit Annual Cr 107
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 36
Cash from Investing Activity Annual Cr 8-15
Cash from Financing Annual Activity Cr -17
Net Cash Flow Annual Cr 10-2
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 152139
Fixed Assets Annual Cr 6847
Total Non Current Assets Annual Cr 9396
Total Current Assets Annual Cr 126114
Total Assets Annual Cr 220210
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 9790
ROE Annual % 75
ROCE Annual % 118
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1512

Kilitch Drugs(I) Technicals

EMA & SMA

Current Price
₹349.65
-7.1 (-1.99%)
pointer
  • Bullish Moving Average
  • ___
  • 15
  • Bearish Moving Average
  • ___
  • 1
  • 20 Day
  • ₹330.19
  • 50 Day
  • ₹298.76
  • 100 Day
  • ₹264.84
  • 200 Day
  • ₹230.89
  • 20 Day
  • ₹331.66
  • 50 Day
  • ₹295.24
  • 100 Day
  • ₹247.21
  • 200 Day
  • ₹212.40

Kilitch Drugs(I) Resistance and Support

PIVOT
₹349.65
Resistance
First Resistance 349.65
Second Resistance 349.65
Third Resistance 349.65
RSI 74.23
MFI 86.41
MACD Single Line 15.82
MACD 16.49
Support
First Resistance 349.65
Second Resistance 349.65
Third Resistance 349.65

Kilitch Drugs(I) Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 4,175 417,500 100
Week 14,337 1,433,740 100
1 Month 16,741 1,674,105 100
6 Month 14,782 1,478,237 100

Kilitch Drugs(I) Result Highlights

Kilitch Drugs(I) Synopsis

NSE-Medical-Diversified

Kilitch Drugs(I) is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 117.78 Cr. and Equity Capital is Rs. 15.58 Cr. for the Year ended 31/03/2023. Kilitch Drugs(I) Ltd. is a Public Limited Listed company incorporated on 12/05/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1992PLC066718 and registration number is 066718.
Market Cap 562
Sales 134
Shares in Float 0.50
No of funds 1
Yield 0.51
Book Value 2.78
U/D Vol ratio 2.3
LTDebt / Equity
Alpha 0.34
Beta 0.6

Kilitch Drugs(I)

Owner NameSep-23Jul-23Jun-23Mar-23
Promoters 69.23%69.23%68.25%68.25%
Mutual Funds
Insurance Companies
Foreign Portfolio Investors
Financial Institutions/ Banks
Individual Investors 26.13%26.5%27.4%27.49%
Others 4.64%4.27%4.35%4.26%

Kilitch Drugs(I) Management

Name Designation
Mr. Mukund P Mehta Managing Director
Mr. Bhavin Mukund Mehta Whole Time Director
Mrs. Mira B Mehta Whole Time Director
Mr. Hemang Engineer Independent Director
Mr. Venkita Subramanian Rajan Independent Director
Prof. Vasudev Krishna Murti Independent Director

Kilitch Drugs(I) Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Kilitch Drugs(I) Corporate Action

Date Purpose Remarks
2023-11-09 Quarterly Results
2023-08-11 Quarterly Results
2023-07-22 Others To consider and approve conversion of warrants into the equity shares of the Company to the specified person only. per share(5%)Final Dividend
2023-05-29 Audited Results
2023-02-14 Quarterly Results

Kilitch Drugs(I) FAQs

What is Share Price of Kilitch Drugs(I) ?

Kilitch Drugs(I) share price is ₹349 As on 10 December, 2023 | 22:21

What is the Market Cap of Kilitch Drugs(I) ?

The Market Cap of Kilitch Drugs(I) is ₹562.3 Cr As on 10 December, 2023 | 22:21

What is the P/E ratio of Kilitch Drugs(I) ?

The P/E ratio of Kilitch Drugs(I) is 40.1 As on 10 December, 2023 | 22:21

What is the PB ratio of Kilitch Drugs(I) ?

The PB ratio of Kilitch Drugs(I) is 3.7 As on 10 December, 2023 | 22:21

Q2FY23